News & Events

NEWS ARTICLES

Richard Lanigan appointed president

Richard Lanigan is a 1981 graduate of the University of Notre Dame

Publication: PR Newswire

November 20, 2006


IRVINE, Calif., Nov. 20 /PRNewswire-FirstCall/ -- Cardiogenesis Corporation (OTC: CGCP), a leading developer of surgical products and accessories used in angina-relieving procedures, announced today that the board of directors has appointed Richard P. Lanigan, 47, as President effective November 15, 2006. Mr. Lanigan will report directly to the company's board of directors. Joseph Kletzel, II, the company's interim Chief Operating Officer since May 2006 and interim Chief Executive Officer since July 2006, has resigned from those positions and has assumed the role of Executive Chairman.

Mr. Lanigan, age 47, has been the Company's Senior Vice President of Operations since November 2005. Prior to November 2005, Mr. Lanigan served in a variety of different capacities. From November 2003 to October 2005, Mr. Lanigan was Senior Vice President of Marketing. From March 2001 to October 2003, Mr. Lanigan was Vice President of Government Affairs and
Business Development. From March 2000 to March 2001, Mr. Lanigan served as Vice President of Sales and Marketing and from 1997 to 2000, he was the Director of Marketing. From 1992 to 1997, Mr. Lanigan served in various positions, most recently Marketing Manager, at Stryker Endoscopy. From 1987 to 1992, Mr. Lanigan served in Manufacturing and Operations management at Raychem Corporation. From 1981 to 1987, he served in the U.S. Navy where he completed six years of service as Lieutenant in the Supply Corps. Mr. Lanigan earned a Bachelors in Business Administration from the University of Notre Dame and a Masters of Science in Systems Management from the University of Southern California.

Commenting on Mr. Kletzel's new role as executive chairman, Richard Lanigan noted, "We very much appreciate the contributions Joe has made during the last three years and, especially his leadership during the past six months. We look forward to his continued support and guidance in his new role."

###